Home › Free Stock Grades › MGTX
MeiraGTx Holdings plc (MGTX) Stock Grade
MGTX · Healthcare
A+
Market Cap
$639.4M
P/E Ratio
—
Revenue Growth (YoY)
+144.6%
Net Margin
-140.3%
Return on Equity
1971.4%
Dividend Yield
None
About MeiraGTx Holdings plc's fundamentals
MeiraGTx Holdings is a biotech company with a market capitalization of $639.4 million that reported exceptional revenue growth of 144.6% year-over-year, indicating rapid commercial expansion. However, the company posted a net loss in its latest annual statement with a net margin of -140.3%, meaning expenses significantly exceeded revenues. The company does not currently pay a dividend, which is typical for loss-making biotech firms reinvesting capital into research and development.